HealthTech · 2026
HealthTech Leadership Report
Executive talent at the intersection of medicine, data, and digital health
Executive Summary
AI now accounts for 46% of all global healthcare investment — more than $18 billion in 2025 alone — making it the dominant capital story in the sector. SVB's 17th Annual Healthcare Investments & Exits Report (January 2026) found that total healthcare VC reached $46.8B in 2025, down 12% from $53.2B in 2024 and well below the $68.3B peak in 2021, while healthcare-focused VCs raised just $7B in new funds — down from the $41B peak. SVB characterised 2025 as a year of 'barbells, bookends, and have-nots': mega-rounds for AI incumbents, brutal conditions for the middle market. McKinsey's digital health research places Europe as the world's largest digital health market at $143.87 billion in 2025 — 34.67% of global spend — growing at 9.4% annually toward a 2035 forecast of $353 billion. The executives who understand both the clinical and commercial dimensions of this market are the most competed-for leadership profiles in European technology.
The defining tension in HealthTech in 2026 is the gap between AI adoption ambition and operational delivery. BCG's research identifies this precisely: healthcare is the second-fastest-growing enterprise AI segment — with an eightfold increase in AI customer growth from 2024 to 2025 — yet 'the promise of AI to transform provider operations has not yet been realized; while pilots have been promising, most have failed to scale.' 22% of US healthcare organisations have implemented domain-specific AI tools — a 7× increase over 2024 — compared to fewer than 9% of companies across other industries. Meanwhile, McKinsey found that 50% of healthcare leaders say their organisations have already implemented generative AI, and 92% plan to increase AI budgets within three years. The executives who can convert that investment into operational outcomes are the most commercially critical hire in the sector.
The underlying workforce crisis compounds every other leadership challenge in HealthTech. The WHO estimates demand for healthcare workers will rise to 18.2 million across Europe by 2030 against a current supply of 8.6 million nurses, midwives, and healthcare assistants — a gap driven by population ageing, burnout, and rising chronic disease prevalence. KPMG's Healthcare CEO Outlook 2025 — surveying 110 healthcare CEOs across 11 markets — found that 87% plan to invest more than 10% of budgets in AI in the coming year, 83% expect ROI within three years, and 71% are focused on retaining and retraining high-potential talent. Regulatory complexity — MDR, GDPR health data processing, the EU Health Data Space, and MDR/UKCA post-Brexit — adds further constraint: the executives who combine clinical credibility, AI fluency, and regulatory depth are found in a genuinely small population across Europe.
Key Findings
AI is 46% of all healthcare investment — but most implementations are failing to scale
SVB's January 2026 report found that AI healthcare investment reached $18B+ in 2025 — 46% of total sector investment — with more deals above $300M than in any previous year (40% of AI spending, up from 31% in 2024). Yet BCG's research is unambiguous: 'The promise of AI to transform provider operations, experience, and financials has not yet been realized — while pilots have been promising, most have failed to scale.' The executives who can bridge from pilot to production — translating AI capability into workflow redesign, clinical governance, and measurable patient outcomes — are the single most valuable category of HealthTech hire in 2026.
Consumers are ready for AI healthcare — health systems are structurally unprepared
BCG's 2026 research found that GenAI tools are now 'the first destination' for many patients seeking health advice, with close to half of US adults using health apps and roughly one-third using health-tracking wearables. Health spending is rising at nearly three times the rate of GDP — incremental efficiency gains are insufficient. Yet health systems lack the operational infrastructure and the executive leadership to capture AI's productivity potential: pilots are running, but enterprise-scale implementation is rare. The CCOs, COOs, and CTOs who can align patient-facing AI tools with health system procurement cycles, clinical governance, and regulatory requirements are the defining hire for companies selling into NHS, German Krankenkassen, or EU health systems.
Clinical Chief Medical Officers are the defining hire for AI diagnostics companies
AI diagnostics businesses — radiology AI, pathology AI, clinical NLP — require a Chief Medical Officer who is both a practising or recently practising clinician and capable of operating within a technology startup environment. McKinsey's US Gen AI Healthcare Survey found that 80%+ of healthcare organisations have deployed their first gen AI use cases to end users, but that implementation barriers — including data readiness and clinical validation — are now equally urgent as safety risks. The CMO who can lead both the clinical validation process and the FDA/CE regulatory pathway is found in a very small population of executives, and almost none of them are actively job-seeking.
87% of healthcare boards are investing heavily in AI — but only 12% are confident on sustainability
KPMG's Healthcare CEO Outlook 2025 (110 healthcare CEOs, revenues above $500M) found that 87% plan to invest more than 10% of budgets in AI, and 83% expect ROI within three years. Yet only 12% are highly confident about meeting Net Zero targets by 2030, and only 30% are integrating sustainability costs into capital decisions. This reveals a leadership gap: the operational execution of AI, and the ESG accountability that increasingly defines institutional investor relationships and NHS/EU procurement requirements, both require executives who were barely in scope for healthcare leadership roles five years ago.
Health data infrastructure is creating a new class of executive role
The EU Health Data Space, combined with the growth of real-world evidence platforms and population health analytics, is creating demand for Chief Data Officers who understand healthcare data governance, interoperability standards (HL7 FHIR), and the commercial value of health datasets. McKinsey identified mHealth as the fastest-growing sub-segment in European digital health (20% CAGR), driven by the convergence of wearables, continuous monitoring, and AI-enabled diagnosis — all of which depend on data architecture leadership that most HealthTech companies have not yet built. KPMG found 55% of healthcare CEOs are concerned about data readiness — an unusually high proportion for a C-suite metric.
Market Landscape
European HealthTech Landscape
McKinsey's research positions Europe as the world's largest digital health market at $143.87 billion in 2025 — 34.67% of global spend — with the software segment at 61.6% of market value and mHealth growing at 20% CAGR. The UK leads European investment, with NHS partnerships, MHRA regulatory frameworks, and a deep academic medical base at Oxford, Cambridge, and Imperial College. Germany's Digitale-Versorgung-Gesetz (DVG) — enabling digital health apps to be prescribed by doctors — has created a regulatory model studied globally. Switzerland and Sweden are significant hubs for medtech and life sciences data infrastructure.
The WHO's projection of 18.2 million healthcare workers needed across Europe by 2030 against current supply of 8.6 million creates a structural demand for technology leadership in healthcare productivity. AI-enabled workflow tools, clinical decision support, and population health platforms are growing faster in Europe than anywhere else — which is precisely why the competition for executive talent with both clinical credibility and technology product experience is so acute.
The AI Investment Bifurcation
SVB's characterisation of 2025 as 'barbells, bookends, and have-nots' captures the bifurcation that defines HealthTech investment today. AI incumbents with proven clinical validation are attracting mega-rounds — more $300M+ deals than any prior year — while the middle market faces a funding environment where VC fund formation has collapsed from a $41B peak to $7B in 2025. Total deal count fell 7% to 2,517. This means the executive talent market is simultaneously very active (well-capitalised AI incumbents hiring aggressively) and highly constrained (mid-market companies unable to offer competitive equity packages). The search for clinical-tech executives has become a zero-sum competition between a small number of well-capitalised competitors.
Leadership & Talent Trends
Roles in Highest Demand
Chief Medical Officer (clinical AI credibility), Chief AI Officer (healthcare-specific), VP of Clinical Affairs, Head of Regulatory Affairs (MDR/UKCA/FDA), Chief Commercial Officer (health system focus), VP of Health System Partnerships, Chief Data Officer (health data governance and FHIR), and VP of AI & Data Science are the most consistently requested profiles. CTOs in this sector are expected to have working knowledge of GDPR health data requirements, FHIR interoperability standards, and increasingly, AI model governance and clinical validation frameworks.
The AI implementation gap identified by BCG — promising pilots failing to scale — creates particularly acute demand for COOs and VP of Operations profiles who have successfully deployed AI tools across clinical workflows in NHS, hospital network, or integrated care environments. These executives, who sit at the intersection of clinical credibility and operational change management, are among the rarest profiles in European HealthTech.
Where the Best Candidates Come From
The most valued executive backgrounds in HealthTech combine NHS or health system leadership (senior clinicians, NHS Digital executives, NHSX alumni) with technology product or scale-up experience. Life sciences consulting backgrounds — McKinsey Health, KPMG health practice, Deloitte Digital — are increasingly competitive for CFO, strategy, and Chief Data Officer roles where regulatory fluency and financial modelling are both required.
KPMG's finding that 71% of healthcare CEOs are focused on retaining and retraining high-potential talent reflects the extent to which internal development is now as important as external hiring. The best HealthTech boards are building both pipelines simultaneously — developing clinical executives into commercial roles while recruiting technology leaders who can credibly engage clinical stakeholders. The ability to assess both dimensions — technical and clinical — is what distinguishes specialist search from generalist approaches in this sector.
Key Search Perspective
Key Search has placed senior leadership teams at digital health businesses across the full spectrum — from AI diagnostics startups to established telehealth platforms and health data infrastructure companies. The data from SVB, BCG, McKinsey, and KPMG tells a consistent story: AI investment is at record levels, the digital health market in Europe is the largest in the world and growing at nearly 10% annually, and yet most AI implementations are failing to scale. The executives who can close that gap — combining clinical credibility, AI operational experience, and regulatory fluency — are found in a genuinely small population across Europe, and almost none of them are actively looking.
Our most important insight from years of HealthTech search is that the brief matters more here than in almost any other sector. BCG is precise about this: 'consumers are ready for AI-enabled health care; health systems need to be too' — which means the commercial profile needed to sell into an NHS trust is fundamentally different from the profile needed to sell into a consumer health app. A HealthTech company selling to GP practices needs a very different CCO than one selling to hospital trusts or integrated care systems. We build the regulatory environment, the customer stakeholder complexity, and the clinical context into every search brief — and that specificity is what determines whether the executive thrives or exits in Year 1.
Looking to hire in HealthTech?
Talk to our HealthTech specialists about your next executive hire.
Report Details
- Publisher
- Key Search
- Updated
- 2026
- Read Time
- 11 minutes
- Access
- Free
- Coverage
- EMEA
9–12 Nov 2026 · MEO Arena, Lisbon
